se of Urinary Neutrophil Gelatinase Associated Lipocalin (uNGAL) in predicting spontaneous bacterial peritonitis in cirrhosis.
Not Applicable
- Conditions
- Health Condition 1: K703- Alcoholic cirrhosis of liverHealth Condition 2: K721- Chronic hepatic failureHealth Condition 3: K652- Spontaneous bacterial peritonitis
- Registration Number
- CTRI/2021/09/036783
- Lead Sponsor
- Taurus Life Sciences Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of decompensated cirrhosis of liver with ascites, with a diagnostic paracentesis done at current admission.
Exclusion Criteria
Pre-existing renal disease/CKD, AKI at the time of hospitalization, renal replacement therapy, secondary peritonitis, malignant diseases, prior antibiotic therapy, urinary tract infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of spontaneous bacterial peritonitis and prognosisTimepoint: At time of recruitment and at the end of 30 days (day 0 and day 30)
- Secondary Outcome Measures
Name Time Method Comparision of urinary NGAL level with renal dysfunctionTimepoint: Day 0;To co-relate uNGAL levels with other ascitic parametersTimepoint: Day 0;TO compare uNGAL and survivalTimepoint: Day 30;To compare uNGAL in SBP and non-SBP groupTimepoint: Day 0